NCT00704782View on ClinicalTrials.gov

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Alzheimer's Disease
Interventions
DRUG

dimebon

Trial Locations (4)

85004

Xenoscience, Inc., Phoenix

85006

Banner Alzheimer's Institute, Phoenix

85013

Barrow Neurological Institute, Phoenix

85351

Sun Health Research Institute, Sun City

Sponsors

Lead Sponsor

Medivation, Inc.
All Listed Sponsors
lead

Medivation, Inc.

INDUSTRY

NCT00704782 - Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter